Atlas Trials

Effect of Natalizumab on Infarct Volume in Acute Ischemic Stroke

Clinical trial NCT01955707 · COMPLETED

Trial details

NCT number
NCT01955707
Sponsor
Biogen
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Acute Ischemic Stroke
Start date
2014-01-01
Primary completion
2015-02-01
Enrollment
161

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.